Inventories

12 Months Ended

Dec. 31, 2022

Inventory Disclosure [Abstract]

Inventories

Note 5. Inventories

Inventories consisted of the following (in thousands):

	December 31,
	2022		2021
Raw materials	$	—	$	911
Work in process		—		70
Finished goods		—		5
Inventories	$	—	$	986

Due to the RIF and the Company’s decision to discontinue enrollment of patients in its atherectomy clinical trial, the Company suspended manufacturing activities in June 2022 and disposed of all inventories, resulting in a write-down of $1.0 million to net realizable value of its inventories. Such expense is included in restructuring and impairment charges in the statement of operations for the year ended December 31, 2022. See Note 14. Restructuring and Impairment Charges.